Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Signia Announces Insio Charge&Go AX

Expanding on its mission to enhance human performance, hearing aid innovator Signia today announced the general availability of its Insio Charge&Go AX custom hearing aids, the newest revolutionary device built upon Signia’s pioneering Augmented Xperience (AX) platform.

The first of its kind AX platform utilizes Signia’s ground-breaking Augmented Focus™ technology, which processes speech and background noise separately—using two dedicated processors—and combines them to deliver outstanding speech clarity in a fully immersive soundscape. Signia AX makes it possible for patients to focus on what they truly want to hear.

Signia Insio Charge&Go AX and Signia AX were recently named CES 2022 Innovation Awards Honorees in the Wearables and Accessibility categories, recognizing Signia’s success in optimizing listening through its iconic innovations.[1]

The Insio Charge&Go AX is the second family of Signia hearing aids built upon the AX platform, following the successful Spring 2021 launch of the Pure Charge&Go T AX RIC hearing aids. The Insio Charge&Go AX is the industry’s first family of custom-fitted in-the-canal (ITC) and in-the-ear (ITE) hearing aids to feature contactless charging, Bluetooth® connectivity, and the ability to stream from Android and Apple iOS devices. Because they are designed to fit comfortably in the patient’s ear, they also deliver the discretion that today’s hearing aid wearers demand.

“By taking the Augmented Xperience platform and adapting it for use in our newest custom hearing aids, Signia continues to combine world-class audiology and world’s first technologies to enhance human performance,” said Dr. Brian Taylor, Senior Director of Audiology for Signia. “The Insio Charge&Go AX hearing aids join the widely acclaimed, ground-breaking Pure Charge&Go T AX rechargeable RIC hearing aids in giving hearing care professional a wider range of solutions to fit patients’ needs, wants, and styles.”

Designed For All Patients’ Needs

Both the ITC and ITE Insio Charge&Go AX custom hearing aids are fully rechargeable and designed to support a broad range of patients’ needs. They come with a contactless charger for easy operation, meaning wearers don’t have to worry about charging positions when ensuring maximum battery life. And they connect seamlessly to iPhones and ASHA-compatible Android devices and feature convenient push-button control of smartphone functions.

All Insio Charge&Go AX custom hearing aids are designed for a high fitting rate. They are uniquely small and customized to the wearer’s ear canal for all-day comfort and higher patient satisfaction. They also come in a range of colors including Black, Dark Brown, Brown, Mocha, Tan, and Beige.

“As with all our hearing aids, we’re not just looking to help correct a loss,” stated Taylor. “Through iconic innovation and a consumer-centric approach, Signia also aims to give patients an edge. Our new custom, AX-based hearing aids are the first custom hearing aid with contactless charging that can be tailored to both the patient’s hearing loss and ear anatomy.”

According to studies, Signia AX results in greater than 25 percent better speech understanding in noise compared to users’ own hearing aids.[2] And 95 percent of study participants reported

exceptional speech understanding in their home environment.[3]

Backed by the Power of the Signia app

Like other Signia hearing aids, the new Insio Charge&Go AX hearing aids come with the award-winning Signia app, providing on-the-go support and intuitive access to hearing aid controls.

The Signia App provides wearers with streaming capabilities; tinnitus therapy; the AI-based Signia Assistant for a more personalized listening experience and 24/7 digital support; Signia Telecare for remote care support; and much more. It also allows wearers to activate Signia’s first-of-its-kind Face Mask Mode, which dramatically improves audibility for wearers communicating with someone in a face mask.


[1] The CES Innovation Awards are based upon descriptive materials submitted to the judges. CTA did not verify the accuracy of any submission or of any claims made and did not test the item to which the award was given.

[2] Signia White Paper. Based on transformation of the 1.8 dB SNR improvement using a value of the slope of the psychometric function (Wagener & Brand, 2005)

[3] Signia White Paper. 18/19 participants had a mean rating of speech intelligibility-related questions of more than 8.0 and 9.0, respectively

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy